VisMederi Holding

Improving human health

VisMederi Holding

VisMederi Holding is the company that holds a qualified share of the companies that are part of the VisMederi Group. The Group of VisMederi Holding operates in various business areas all related to Research and Innovation in the fields of Public Health, Life Sciences and Biotechnologies and is composed of VisMederi Srl, VisMederi Research Srl, VisMederi Life Sciences Srl, VisMederi Textyle Srl, VisMederi Pharma Srl, ETHS – Education and Training for Health Sciences Srl with single shareholder, Accurange Srl.

Vismederi Holding
0Mln €

Revenues

0

Employees 

0Paesi

Global Partnerships

Vismederi Holding: latest news

All the news of the group

Nov 03 2025

Development and Qualification of the Shigella Multiplex Assay: New Publication Highlights Major Collaborative Milestone

A new milestone in bacterial vaccine research: after several years of intensive research, validation work, and cross-institutional collaboration,...
Oct 23 2025

VisMederi contributes to Clover Biopharmaceuticals’ advancement in innovative respiratory combination vaccines

We are proud to be part of Clover Biopharmaceuticals’ important achievement in advancing innovative respiratory combination vaccines. VisMederi...
Oct 22 2025

VisMederi at the 10th ESWI Influenza Conference in Valencia

VisMederi continues to strengthen its engagement in metapneumovirus control and vaccine research, confirming its active role in the international...
Oct 17 2025

Inspiring and productive week at the World Vaccine Congress Europe 2025 in Amsterdam

Our team wrapped up an inspiring and productive week at the World Vaccine Congress Europe 2025 in Amsterdam — the leading European event dedicated...
Oct 16 2025

Project Director Luisa Ganfini was invited by Osivax and ClinChoice to Verona to participate in the recent Investigator Meetin

During the event, Luisa presented the key role that VisMederi will play in the upcoming Phase 2b clinical study. The meeting provided a valuable...
Oct 16 2025

VisMederi’s Cell Mediated Immunity Team members in Sofia to deliver a training session at Hera Medical Center

VisMederi's Cell Mediated Immunity (CMI) Team members, Ilaria Razzano and Ilaria Ferrigno, traveled to Sofia to deliver a training session at Hera...
Aug 05 2025

New paper on the use of pseudotyped viral vectors to study the antibody-mediated immune responses

A new paper from our team is online. The paper dissects the use of pseudotyped viral vectors to study the antibody-mediated immune responses. The...
Aug 01 2025

VisMederi has officially adopted an Organizational, Management and Control Model pursuant to Legislative Decree 231/2001

In line with its commitment to strengthening internal control systems and aligning with the core values of its governance, VisMederi has officially...
Jul 03 2025

The journal Parasites & Vectors has published a new article resulting from the historic collaboration between VisMederi and the University of Milan

The journal Parasites & Vectors has published a new article resulting from the historic collaboration between VisMederi and the University of...
Jun 03 2025

VisMederi Foundation welcomes the students from Kent University

As part of the Florence Health Institute program, the VisMederi Foundation, that's part of the VisMederi Group, greeted a group of Kent State...

Where we

are

 

 

 

 

 

 

The

founder

Emanuele Montomoli is Full Professor of Hygiene and Public Health at the University of Siena, Italy. He received his BSc and MSc in Life Sciences from the University of Siena, Italy in 1997 and he earned his MBiochem in 2001.